For years, America’s leading retailers have benefited from a little-known program that helps to resolve meritless patent disputes, called Inter Partes Review. Congress created the IPR process in 2012 ...
An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.
When patent infringement threatens a company’s business and possibly even puts its survival at risk, effective patent litigation can become a necessity. The cost to litigate a patent case in the U.S., ...
While there's no definitive consensus, economists are closely monitoring the possibility of entering a recession this year. Economists agree a recession is not imminent, but caution the odds of facing ...
"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder involvement in a patent infringement action be revealed? This article tackles this ...
The Rise of ‘Settled Expectations’ In USPTO Review and the Fallout for Patent Owners and Challengers
The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their strategies to ensure they are not left behind by the USPTO’s new approach. The ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
"seven patents covering hybrid bonding technology and three patents covering advanced process node technology." How does a lawsuit like this even work when AMD does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results